Matt Stange

Matt Stange is a seasoned professional in the pharmaceutical and healthcare industries, currently serving as the Director of Commercial at Capricor Therapeutics, Inc. since June 2025. Stange's prior experience includes the role of Vice President of Business Development at AdhereTech and Global Marketing & Commercial Strategy Leader at Otsuka Pharmaceutical Companies, where notable achievements include spearheading the global launch of Sibeprenlimab and leading HCP marketing efforts for the launch of Abilify Asimtufii. Stange began a career in sales and marketing at Emware Emergency Systems and held an earlier position as the Assistant Manager of Immunology Research & Lab Operations at UC Davis Medical Center. Stange earned an MBA from Auburn University's Harbert College of Business and a B.S. in Microbiology and Immunology from the University of California, Davis.